Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Qualia Life Sciences LLC is navigating 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The company's current prosecution involves 1 distinct examiner and 1 distinct art unit. This reflects a highly centralized prosecution phase where the company's intellectual property is being evaluated through a single administrative channel at the patent office.
The busiest examiner for the portfolio is GONZALEZ, LUISALBERTO, who is assigned 1 busiest examiner pending action. This count represents the total 1 pending office action for the company. Because the company is only active in 1 distinct art unit, the prosecution strategy is entirely dependent on the specific examination environment of that unit. Practitioners should recognize that the company's current success in the Biotechnology & Pharmaceuticals sector is tied to the specific review of Luisalberto Gonzalez.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GONZALEZ, LUISALBERTO | 1 | 59.4% | +47.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18202051 | COMPOSITIONS FOR A DIETARY SUPPLEMENT TO MANAGE SENESCENT CELLS | GONZALEZ, LUISALBERTO | 13d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18202051 | COMPOSITIONS FOR A DIETARY SUPPLEMENT TO MANAGE SENESCENT CELLS | GONZALEZ, LUISALBERTO | 13d |
| Art Unit | Apps |
|---|---|
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18202051 | COMPOSITIONS FOR A DIETARY SUPPLEMENT TO MANAGE SENESCENT CELLS | GONZALEZ, LUISALBERTO | 1624 | §102§103§112 | Non-Final OA | 13d | Pending | May 25, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial